BIOSPRING THE NUCLEIC ACID COMPANY
Live / Registered — Registered (as of 30 Apr 2024)
What this means for you
Registered since 30 Apr 2024. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 30 Apr 2030: the §8 declaration of use).
Record
- Serial number
- 97099607
- Registration number
- 7375011
- Mark type
- Design + words
- Filed
- 29 Oct 2021
- Published for opposition
- 08 Nov 2022
- Registered
- 30 Apr 2024
- Next maintenance filing
- §8 declaration of use, due by 30 Apr 2030 (grace period to 30 Oct 2030)
- Attorney of record
- Julie A. Katz
Goods and services
- Class 001 — Chemicals: Nucleic acid for laboratory or research use; Nucleic acid for use in the manufacture of pharmaceuticals; Oligonucleotides for laboratory or research use; Oligonucleotides for use in the manufacture of pharmaceuticals
- Class 005 — Pharmaceuticals: Nucleic acid for medical diagnostic purposes; Oligonucleotides for medical diagnostic purposes; Oligonucleotides for pharmaceutical purposes
- Class 042 — Scientific and technological services: Scientific research services, namely, nucleic acid analysis; Scientific research services, namely, oligonucleotide analysis
Owner
- BioSpring Gesellschaft für Biotechnologie mbH, Frankfurt, DD
- BioSpring Gesellschaft für Biotechnologie mbH, Frankfurt, DD
- BioSpring Gesellschaft für Biotechnologie GmbH, Frankfurt, DE
Prosecution history
- 30 Apr 2024 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 30 Apr 2024 — REGISTERED-PRINCIPAL REGISTER
- 26 Mar 2024 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 25 Mar 2024 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 08 Mar 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 08 Mar 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 07 Mar 2024 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 12 Feb 2024 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 12 Feb 2024 — FINAL REFUSAL E-MAILED
- 12 Feb 2024 — SU - FINAL REFUSAL - WRITTEN
- 16 Jan 2024 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 16 Jan 2024 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 16 Jan 2024 — ASSIGNED TO LIE
- 23 Aug 2023 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 21 Aug 2023 — NOTIFICATION OF NON-FINAL ACTION E-MAILED